The Default Referral Choice Strategy for Specialty Practices

Bypaulgruensfelder
Luminus — Healthcare Marketing Edge Podcast (EP 14) February 10, 2026
Read Full Article →
AI-Generated Summary

Will Ross of Origins Spine & Joint outlines the strategy his practice used to become the default referral destination for referring providers in their market. The approach combines relationship development with primary care physicians, consistent delivery of clinical outcomes, and a proactive digital review strategy. He stresses that referral pipelines require as much intentional management as direct patient acquisition channels.

Why It Matters

Specialty practices and surgery centres with high referral dependence often under-invest in referral relationship management. Ross provides an operational blueprint applicable across musculoskeletal, surgical, and other specialty settings.

growth strategy referrals reviews conversion specialty practice relationship marketing

While we aim to share useful and relevant resources, we can’t guarantee the accuracy of all third-party content. Always apply professional judgment when acting on information from external sources.

Similar Posts

  • Home-Based Care M&A Q2 2026: 16 Deals, $4B in Mega-Platform Buys

    Bypaulgruensfelder

    Home-based care M&A volume fell to 16 closed deals in Q2 2026 — down from 27 in Q1 and 29 a year earlier — even as two of the largest transactions on record closed: General Atlantic’s $3 billion acquisition of TEAM Services Group and Kinderhook Industries’ $1.1 billion take-private of Enhabit. According to Mertz Taggart’s Q2 2026 home-based care M&A report, hospice and home care tied at eight deals each, followed by skilled home health at six, with two additional deals announced but not yet closed. Advisers attribute the lower count partly to a tougher regulatory backdrop — fraud takedowns, the hospice 36-month rule, and a new enrollment moratorium — making transactions more complex to close.

  • MGMA 2026: Only 47% of Medical Groups Report Rising Revenue as Costs Climb

    Bypaulgruensfelder

    Medical practice revenue growth is stalling in 2026 even as costs keep climbing. MGMA’s June 30, 2026 poll found just 47% of medical groups reporting higher year-to-date revenue versus 2025, with 36% reporting a decline—narrowing the gainers’ lead from 26 points a year ago to only 11. Meanwhile 84% report higher operating costs. Two forces drive the squeeze: the 2026 Medicare Physician Fee Schedule’s -2.5% work-RVU efficiency adjustment on 7,000+ procedural codes, and ACA marketplace erosion—effectuated enrollment fell to 19.2 million, roughly 3 million below 2025, as average deductibles jumped 37% to a record $3,786. MGMA urges practices to model Medicare impact by CPT code and refresh payer-mix projections now.

  • Jarrard 2026 Survey: Community Impact Drives Hospital Trust and Patient Choice

    Bypaulgruensfelder

    Hospitals seen as strong community partners earn markedly higher consumer trust, advocacy, and preference, according to Jarrard’s 2026 Community Impact Survey — yet fewer than one-third of consumers strongly agree their local hospital is a good community partner. Consumers who do hold that view are 26 points more likely to trust the hospital to do the right thing, 37 points more likely to speak positively about or defend it, 33 points more likely to advocate for it on policy issues, and 24 points more likely to choose it when all else is equal (15 points more likely even when less convenient). Jarrard frames visible community impact as a business imperative tied directly to loyalty and choice.

  • Hospital Mergers as a Lifeline: What Actually Creates Value

    Bypaulgruensfelder

    Hospital mergers are increasingly a survival move rather than a growth play, as roughly $1 trillion in Medicaid cuts under the One Big Beautiful Bill Act and ACA changes squeeze margins and raise uncompensated care. Independent and rural hospitals that lack capital for technology and service expansion are seeking larger partners, but stricter state regulatory reviews now threaten deal timelines — Oregon’s Santiam Hospital warned it could become insolvent by August 1 without an expedited merger. Optum Advisory’s Morgan Haines stresses that “the merger itself is never the value”; stabilization comes from post-close investments in technology, service-line redesign, operational improvements, and community partnerships. Leaders are urged to prioritize “speed-to-value.”

  • Why AI ROI Stalls: The Case for Disciplined Decisions

    Bypaulgruensfelder

    AI initiatives often underdeliver because organizations never define which decisions AI should actually improve — a fixable focus problem, not a technology gap. Summit Partners’ Sharon Lin argues that generative AI has lowered the cost of analysis so dramatically that many teams now face “analysis paralysis at scale,” producing endless dashboards and scenarios while struggling to act. She warns against automating away interpretive, relational work — consultative sales, creative brainstorming, customer insight — where friction itself carries signal. The limiting factor in AI-enabled organizations is rarely access to insight or technology; it is the discipline to identify which decisions AI can genuinely improve and the willingness to protect space for human judgment.

  • 2026 Medicare Reimbursement Changes: What the Conversion Factor Update Really Means

    Bypaulgruensfelder

    Medicare reimbursement remains below the cost of delivering care for 80% of medical groups in 2026, according to an MGMA Stat poll of 166 respondents. CMS set the 2026 Physician Fee Schedule conversion factor at $33.57 for Advanced APM participants and $33.40 for non-participants — increases of 3.77% and 3.26% respectively after years of flat or negative updates. A new -2.5% efficiency adjustment on work RVUs for non-time-based services may offset gains at the service-line level. Telehealth flexibilities are extended through December 2027. Medicare Advantage denial strain from prior authorization and downcoding compounds the squeeze, with operating costs per FTE physician rising 63% from 2013 to 2022 while the conversion factor grew just 1.7%.